Interferons and interferon regulatory factors in malaria

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Gun, Sin Yee ^a,b   Claser, Carla ^a   Tan, Kevin Shyong Wei ^b   Rénia, Laurent ^a,b  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR 7; INTERFERON REGULATORY FACTOR 9; INTERLEUKIN 28A; INTERLEUKIN 29; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9;

EXTRACELLULAR MATRIX; HUMAN; INNATE IMMUNITY; MALARIA; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; PLASMODIUM YOELII; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; METABOLISM;

ANIMALS; HUMANS; INTERFERON REGULATORY FACTORS; INTERFERONS; MALARIA;

EID: 84929512247     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/243713     Document Type: Review

References (250)

1. WHO, "World malaria report 2013 shows major progress in fight against malaria, calls for sustained financing, " Tech. Rep. , 2013.
2. A. F. Cowman and S. H. I. Kappe, "Malarias stealth shuttle, " Science, vol. 313, no. 5791, pp. 1245-1246, 2006.
3. M. Giboda, J. Gutvirth, M. Maloveska, F. Kosina, M. Hocmanov a, and V. Struncova, "Imported malaria diagnostic and clinical features, " Bratislavske Lekarske Listy, vol. 88, no. 1, pp. 104-111, 1987.
4. D. J. Perkins, T. Were, G. C. Davenport, P. Kempaiah, J. B. Hittner, and J. M. Ongecha, "Severe malarial anemia: innate immunity and pathogenesis, " International Journal of Biological Sciences, vol. 7, no. 9, pp. 1427-1442, 2011.
5. W. R. J. Taylor, J. Hanson, G. D. H. Turner, N. J. White, and A. M. Dondorp, "Respiratory manifestations of malaria, " Chest, vol. 142, no. 2, pp. 492-505, 2012.
6. R. Idro, N. E. Jenkins, and C. R. J. Newton, "Pathogenesis, clinical features, and neurological outcome of cerebralmalaria, " The Lancet Neurology, vol. 4, no. 12, pp. 827-840, 2005.
7. L. Renia, M. S. Marussig, D. Grillot et al. , "In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a syntheticmalaria peptide, " Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 18, pp. 7963-7967, 1991.
8. L. Schofield and G. E. Grau, "Immunological processes in malaria pathogenesis, " Nature Reviews Immunology, vol. 5, no. 9, pp. 722-735, 2005.
9. J. M. Horne-Debets, R. Faleiro, D. S. Karunarathne et al. , "PD-1 dependent exhaustion of CD8+ T cells drives chronic malaria, " Cell Reports, vol. 5, no. 5, pp. 1204-1213, 2013.
10. K. J. Ewer, G. A. OHara, C. J. A. Duncan et al. , "Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation, " Nature Communications, vol. 4, article 2836, 2013.
11. K. Artavanis-Tsakonas and E. M. Riley, "Innate immune response to malaria: rapid induction of IFN-γ from human NK cells by live Plasmodiumfalciparum-infected erythrocytes, "The Journal of Immunology, vol. 169, no. 6, pp. 2956-2963, 2002.
12. J. Santhanam, L. Raberg, and N. Jon Savill, "Immune-mediated competition in rodentMalaria is most likely caused by induced changes in innate immune clearance of merozoites, " PLoS Computional Biology, vol. 10, no. 1, Article IDe1003416, 2014.
13. L. Molineaux, M. Trauble, W. E. Collins, G. M. Jeffery, and K. Dietz, "Malaria therapy reinculation data suggest individual variation of an innate immune response and independent acquisition of antiparasitic and antitoxic immunities, " Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 2, pp. 205-209, 2002.
14. I. G. Scragg, "Early cytokine induction by Plasmodium falciparum is not a classical endotoxin-like process, " European Journal of Immunology, vol. 29, no. 8, pp. 2636-2644, 1999.
15. H. Brown, G. Turner, S. Rogerson et al. , "Cytokine expression in the brain in human cerebral malaria, " Journal of Infectious Diseases, vol. 180, no. 5, pp. 1742-1746, 1999.
16. I. Angulo and M. Fresno, "Cytokines in the pathogenesis of and protection against malaria, " Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 6, pp. 1145-1152, 2002.
17. E. Tjitra, N. M. Anstey, P. Sugiarto et al. , "Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia, " PLoS Medicine, vol. 5, no. 6, pp. 0890-0899, 2008.
18. S. Ahamada, M. Wery, and R. Hamers, "Rodent malaria parasites: molecular karyotypes characterize species, subspecies and lines, " Parasite, vol. 1, no. 1, pp. 31-38, 1994.
19. S. L. Perkins, I. N. Sarkar, and R. Carter, "The phylogeny of rodent malaria parasites: simultaneous analysis across three genomes, " Infection, Genetics and Evolution, vol. 7, no. 1, pp. 74-83, 2007.
20. F. H. Amante, A. Haque, A. C. Stanley et al. , "Immunemediated mechanisms of parasite tissue sequestration during experimental cerebralmalaria, " Journal of Immunology, vol. 185, no. 6, pp. 3632-3642, 2010.
21. C. Claser, B. Malleret, S. Y. Gun et al. , "Cd8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria, " PLoS ONE, vol. 6, no. 4, Article ID e18720, 2011.
22. J. A. McQuillan, A. J. Mitchell, Y. F. Ho et al. , "Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria, " International Journal for Parasitology, vol. 41, no. 2, pp. 155-163, 2011.
23. F. El-Assaad, J. Whewaya, A. J. Mitchell, and et al, "Cytoadherence of Plasmodium berghei-infected red blood cells to murine brain and lung microvascular endothelial cells in vitro, " Infection and Immunity, vol. 81, no. 11, pp. 3984-91, 2013.
24. C. R. J. C. Newton, T. T. Hien, and N. White, "Cerebral malaria, " Journal of Neurology Neurosurgery & Psychiatry, vol. 69, no. 4, pp. 433-441, 2000.
25. S. C. Wassmer, V. Combes, and G. E. Grau, "Pathophysiology of cerebral malaria: Role of host cells in the modulation of cytoadhesion, " Annals of the New York Academy of Sciences, vol. 992, pp. 30-38, 2003.
26. E. Belnoue, M. Kayibanda, A. M. Vigario et al. , "On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebralmalaria, " Journal of Immunology, vol. 169, no. 11, pp. 6369-6375, 2002.
27. S. W. Howland, C. M. Poh, S. Y. Gun et al. , "Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria, " EMBO Molecular Medicine, vol. 5, no. 7, pp. 984-999, 2013.
28. R. Medzhitov and J. Janeway C. , "Advances in immunology: innate immunity, " The New England Journal of Medicine, vol. 343, no. 5, pp. 338-344, 2000.
29. R. Medzhitov and C. Janeway Jr. , "Innate immune recognition: Mechanisms and pathways, " Immunological Reviews, vol. 173, pp. 89-97, 2000.
30. S. Akira, S. Uematsu, and O. Takeuchi, "Pathogen recognition and innate immunity, " Cell, vol. 124, no. 4, pp. 783-801, 2006.
31. T. Vasselon and P. A. Detmers, "Toll receptors: a central element in innate immune responses, " Infection and Immunity, vol. 70, no. 3, pp. 1033-1041, 2002.
32. T. Kawai and S. Akira, "Toll-like receptor and RIG-1-like receptor signaling, " Annals of the New York Academy of Sciences, vol. 1143, pp. 1-20, 2008.
33. S. Chtarbanova and J. Imler, "Microbial sensing by toll receptors: a historical perspective, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 8, pp. 1734-1738, 2011.
34. A. Cambi and C. G. Figdor, "Dual function of C-type lectinlike receptors in the immune system, " Current Opinion in Cell Biology, vol. 15, no. 5, pp. 539-546, 2003.
35. E. Pyz, A. S. J. Marshall, S. Gordon, and G. D. Brown, "C-type lectin-like receptors on myeloid cells, " Annals of Medicine, vol. 38, no. 4, pp. 242-251, 2006.
36. T. B. H. Geijtenbeek and S. I. Gringhuis, "Signalling through C-type lectin receptors: shaping immune responses, " Nature Reviews Immunology, vol. 9, no. 7, pp. 465-479, 2009.
37. T.-D. Kanneganti, M. Lamkanfi, and G. Nunez, "Intracellular NOD-like receptors in host defense and disease, " Immunity, vol. 27, no. 4, pp. 549-559, 2007.
38. M. Proell, S. J. Riedl, J. H. Fritz, A. M. Rojas, and R. Schwarzenbacher, "TheNod-Like Receptor (NLR) family: a tale of similarities and differences, " PLoS ONE, vol. 3, no. 4, Article ID e2119, 2008.
39. K. Geddes, J. G. Magalhaes, and S. E. Girardin, "Unleashing the therapeutic potential of NOD-like receptors, " Nature Reviews Drug Discovery, vol. 8, no. 6, pp. 465-479, 2009.
40. Y. M. Loo and M. Gale Jr. , "Immune Signaling by RIG-I-like Receptors, " Immunity, vol. 34, no. 5, pp. 680-692, 2011.
41. M. Muzio, D. Bosisio, N. Polentarutti et al. , "Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells, " Journal of Immunology, vol. 164, no. 11, pp. 5998-6004, 2000.
42. V. Hornung, S. Rothenfusser, S. Britsch et al. , "Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides, " Journal of Immunology, vol. 168, no. 9, pp. 4531-4537, 2002.
43. D. Jarrossay, G. Napolitani, M. Colonna, F. Sallusto, and A. Lanzavecchia, "Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells, " European Journal of Immunology, vol. 31, no. 11, pp. 3388-3393, 2001.
44. T. Ito, R. Amakawa, T. Kaisho et al. , "Interferon-α and interleukin-12 are induced differentially by toll-like receptor 7 ligands in human blood dendritic cell subsets, " Journal of Experimental Medicine, vol. 195, no. 11, pp. 1507-1512, 2002.
45. T. B. H. Geijtenbeek, R. Torensma, S. J. Van Vliet et al. , "Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses, " Cell, vol. 100, no. 5, pp. 575-585, 2000.
46. L. F. Poulin, Y. Reyal, H. Uronen-Hansson et al. , "DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues, " Blood, vol. 119, no. 25, pp. 6052-6062, 2012.
47. H. H. Smits, A. Engering, D. Van Der Kleij et al. , "Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin, " Journal of Allergy and Clinical Immunology, vol. 115, no. 6, pp. 1260-1267, 2005.
48. T. B. Geijtenbeek, S. J. vanVliet, E. A. Koppel et al. , "Mycobacteria target DC-SIGN to suppress dendritic cell function, " Journal of Experimental Medicine, vol. 197, no. 1, pp. 7-17, 2003.
49. M. P. Bergman, A. Engering, H. H. Smits et al. , "Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN, " Journal of Experimental Medicine, vol. 200, no. 8, pp. 979-990, 2004.
50. J. Li, Z. Ma, Z. Tang, T. Stevens, B. Pitt, and S. Li, "CpG DNA-mediated immune response in pulmonary endothelial cells, " The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 287, no. 3, pp. L552-L558, 2004.
51. L. Guillott, S. Medjane, K. Le-Barillec et al. , "Response of human pulmonary epithelial cells to lipopolysaccharide involves tolllike receptor 4 (TLR4)-dependent signaling pathways: Evidence for an intracellular compartmentalization of TLR4, "The Journal of Biological Chemistry, vol. 279, no. 4, pp. 2712-2718, 2004.
52. D. Droemann, T. Goldmann, D. Branscheid et al. , "Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung, " Histochemistry and Cell Biology, vol. 119, no. 2, pp. 103-108, 2003.
53. S. Claeys, T. de Belder, G. Holtappels et al. , "Human β-defensins and toll-like receptors in the upper airway, " Allergy, vol. 58, no. 8, pp. 748-753, 2003.
54. C. Maaser, J. Heidemann, C. Von Eiff et al. , "Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin, " Journal of Immunology, vol. 172, no. 8, pp. 5056-5062, 2004.
55. E. Cario and D. K. Podolsky, "Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease, " Infection and Immunity, vol. 68, no. 12, pp. 7010-7017, 2000.
56. A. T. Gewirtz, T. A. Navas, S. Lyons, P. J. Godowski, and J. L. Madara, "Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression, " Journal of Immunology, vol. 167, no. 4, pp. 1882-1885, 2001.
57. S. Frantz, L. Kobzik, Y. Kim et al. , "Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium, " Journal of Clinical Investigation, vol. 104, no. 3, pp. 271-280, 1999.
58. Y. Bulut, E. Faure, L. Thomas et al. , "Chlamydial heat shock protein 60 activates macrophages and endothelial cells through toll-like receptor 4 and MD2 in a MyD88-dependent pathway, " The Journal of Immunology, vol. 168, no. 3, pp. 1435-1440, 2002.
59. T. Imaizumi, S. Aratani, T. Nakajima et al. , "Retinoic acidinducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2, " Biochemical and Biophysical Research Communications, vol. 292, no. 1, pp. 274-279, 2002.
60. B. Opitz, S. Forster, A. C. Hocke et al. , "Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae, " Circulation Research, vol. 96, no. 3, pp. 319-326, 2005.
61. S. Sharma, R. B. DeOliveira, P. Kalantari et al. , "Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome, " Immunity, vol. 35, no. 2, pp. 194-207, 2011.
62. Z. Lu, L. Serghides, S. N. Patel et al. , "Disruption of JNK2 decreases the cytokine response to Plasmodium falciparum glycosylphosphatidylinositol in vitro and confers protection in a cerebral malaria model, " Journal of Immunology, vol. 177, no. 9, pp. 6344-6352, 2006.
63. C. Coban, S. Uematsu, N. Arisue et al. , "Pathological role of Toll-like receptor signaling in cerebral malaria, " International Immunology, vol. 19, no. 1, pp. 67-79, 2007.
64. B. Lepenies, J. P. Cramer, G. D. Burchard, H. Wagner, C. J. Kirschning, and T. Jacobs, "Induction of experimental cerebral malaria is independent of TLR2/4/9, " MedicalMicrobiology and Immunology, vol. 197, no. 1, pp. 39-44, 2008.
65. J. W. Griffith, C. OConnor, K. Bernard, T. Town, D. R. Goldstein, and R. Bucala, "Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host, " Journal of Infectious Diseases, vol. 196, no. 10, pp. 1553-1564, 2007.
66. W. Rudin, N. Favre, G. Bordmann, and B. Ryffel, "Interferon-γ is essential for the development of cerebral malaria, " European Journal of Immunology, vol. 27, no. 4, pp. 810-815, 1997.
67. A. J. Mitchell, A. M. Hansen, L. Hee et al. , "Early cytokine production is associated with protection from murine cerebral malaria, " Infection and Immunity, vol. 73, no. 9, pp. 5645-5653, 2005.
68. C. N. Morrell, K. Srivastava, A. Swaim et al. , "Beta interferon suppresses the development of experimental cerebral malaria, " Infection and Immunity, vol. 79, no. 4, pp. 1750-1758, 2011.
69. G. Senaldi, C. L. Shaklee, J. Guo et al. , "Protection against the mortality associated with disease models mediated by TNF and IFN-γ in mice lacking IFN regulatory factor-1, " Journal of Immunology, vol. 163, no. 12, pp. 6820-6826, 1999.
70. F. E. Lovegrove, S. A. Gharib, S. N. Patel, C. A. Hawkes, K. C. Kain, and W. C. Liles, "Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria, " The American Journal of Pathology, vol. 171, no. 6, pp. 1894-1903, 2007.
71. A. C. Sexton, R. T. Good, D. S. Hansen et al. , "Transcriptional profiling reveals suppressed erythropoiesis, up-regulated glycolysis, and interferon-associated responses inmurinemalaria, " Journal of InfectiousDiseases, vol. 189, no. 7, pp. 1245-1256, 2004.
72. J. Berghout, D. Langlais, and P. Gros, "Irf8-regulated genomic responses drive pathological inflammation during cerebral Malaria, " PLoS Pathogens, vol. 9, no. 7, p. 11, 2013.
73. J. C. R. Hafalla, J. Burgold, A. Dorhoi et al. , "Experimental cerebralmalaria develops independently of caspase recruitment domain-containing protein 9 signaling, " Infection and Immunity, vol. 80, no. 3, pp. 1274-1279, 2012.
74. F. E. Lovegrove, L. Pena-Castillo, N. Mohammad, W. C. Liles, T. R. Hughes, and K. C. Kain, "Simultaneous host and parasite expression profiling identifies tissue-specific transcriptional programs associated with susceptibility or resistance to experimental cerebral malaria, " BMC Genomics, vol. 7, article 295, 2006.
75. N. F. Delahaye, N. Coltel, D. Puthier et al. , "Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malariaresistant mice, " BMC Genomics, vol. 8, article 452, 2007.
76. P. E. van den Steen, N. Geurts, K. Deroost et al. , "Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome, " American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 9, pp. 957-968, 2010.
77. A. Haque, S. E. Best, A. Ammerdorffer et al. , "Type I interferons suppress CD4 + T-cell-dependent parasite control during blood-stage Plasmodium infection, " European Journal of Immunology, vol. 41, no. 9, pp. 2688-2698, 2011.
78. D. Togbe, L. Schofield, G. E. Grau et al. , "Murine cerebral malaria development is independent of toll-like receptor signaling, " The American Journal of Pathology, vol. 170, no. 5, pp. 1640-1648, 2007.
79. E. A. Ball, M. R. Sambo, M. Martins et al. , "IFNAR1 controls progression to cerebral malaria in children and CD8 + T cell brain pathology in plasmodiumberghei-infected mice, " Journal of Immunology, vol. 190, no. 10, pp. 5118-5127, 2013.
80. M. Kordes, K. Matuschewski, and J. C. R. Hafalla, "Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 Is dispensable for induction of experimental cerebral malaria, " Infection and Immunity, vol. 79, no. 9, pp. 3633-3641, 2011.
81. A. Villegas-Mendez, R. Greig, T. N. Shaw et al. , "IFN-γ-producing CD4+ T cells promote experimental cerebralmalaria bymodulating CD8+ T cell accumulation within the brain, " The Journal of Immunology, vol. 189, no. 2, pp. 968-979, 2012.
82. J. Palomo, M. Fauconnier, L. Coquard et al. , "Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA, " European Journal of Immunology, vol. 43, no. 10, pp. 2683-2695, 2013.
83. E. Belnoue, S. M. Potter, D. S. Rosa et al. , "Control of pathogenic CD8+ T cell migration to the brain by IFN-γ during experimental cerebral malaria, " Parasite Immunology, vol. 30, no. 10, pp. 544-553, 2008.
84. S. Epiphanio, M. G. Campos, A. Pamplona et al. , "VEGF promotes malaria-associated acute lung injury in mice, " PLoS Pathogens, vol. 6, no. 5, Article ID e1000916, 2010.
85. J. Wu, L. Tian, X. Yu et al. , "Strain-specific innate immune signaling pathways determine malaria parasitemia dynamics and host mortality, " Proceedings of the National Academy of Sciences, vol. 111, no. 4, pp. E511-E520, 2014.
86. N. M. Gowda, X. Wu, and D. C. Gowda, "TLR9 andMyD88 are crucial for the development of protective immunity to malaria, " The Journal of Immunology, vol. 188, no. 10, pp. 5073-5085, 2012.
87. A. M. Vigario, E. Belnoue, A. Cumano et al. , "Inhibition of Plasmodium yoelii blood-stage malaria by interferon α through the inhibition of the production of its target cell, the reticulocyte, " Blood, vol. 97, no. 12, pp. 3966-3971, 2001.
88. K. Adachi, H. Tsutsui, S. I. Kashiwamura et al. , "Plasmodium berghei infection in mice induces liver injury by an IL-12-and toll-like receptor/myeloid differentiation factor 88-dependent mechanism, " Journal of Immunology, vol. 167, no. 10, pp. 5928-5934, 2001.
89. R. Barboza, A. S. Reis, L. G. da Silva et al. , "MyD88 signaling is directly involved in the development of murine placental malaria, " Infection and Immunity, 2013.
90. C. C. Kim, C. S. Nelson, E. B. Wilson, B. Hou, A. L. DeFranco, and J. L. DeRisi, "Splenic red pulp macrophages produce type I interferons as early sentinels of malaria infection but are dispensable for control, " PLoS ONE, vol. 7, no. 10, Article ID e48126, 2012.
91. Z. Su and M. M. Stevenson, "Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection, " Infection and Immunity, vol. 68, no. 8, pp. 4399-4406, 2000.
92. P. Liehl, V. Zuzarte-Luis, J. Chan et al. , "Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection, " Nature Medicine, vol. 20, no. 1, pp. 47-53, 2014.
93. L. A. Goncalves, L. Rodrigues-Duarte, J. Rodo, L. Vieira de Moraes, I. Marques, and C. Penha-Goncalves, "TREM2 governs Kupffer cell activation and explains belr1 genetic resistance to malaria liver stage infection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, pp. 19531-19536, 2013.
94. H. L. Shear, R. Srinivasan, T. Nolan, and C. Ng, "Role of IFN-γ in lethal and nonlethal malaria in susceptible and resistantmurine hosts, " Journal of Immunology, vol. 143, no. 6, pp. 2038-2044, 1989.
95. J. Miu, N. H. Hunt, and H. J. Ball, "Predominance of interferonrelated responses in the brain during murine malaria, as identified by microarray analysis, " Infection and Immunity, vol. 76, no. 5, pp. 1812-1824, 2008.
96. I. A. Clark, N. H. Hunt, G. A. Butcher, and W. B. Cowden, "Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-γ or tumor necrosis factor, and its enhancement by butylated hydroxyanisole, " The Journal of Immunology, vol. 139, no. 10, pp. 3493-3496, 1987.
97. V. Amani, A. M. Vigario, E. Belnoue et al. , "Involvement of IFN-γ receptor-mediated signaling in pathology and antimalarial immunity induced by Plasmodium berghei infection, " European Journal of Immunology, vol. 30, no. 6, pp. 1646-1655, 2000.
98. C. Voisine, B. Mastelic, A. Sponaas, and J. Langhorne, "Classical CD11c+ dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria, " International Journal for Parasitology, vol. 40, no. 6, pp. 711-719, 2010.
99. J. Zhu, G. Krishnegowda, G. Li, and D. Channe Gowda, "Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of Plasmodiumfalciparumaremainlymediated through the recognition of TLR2/TLR1, " Experimental Parasitology, vol. 128, no. 3, pp. 205-211, 2011.
100. J. Zhu, G. Krishnegowda, and D. C. Gowda, "Inductionof proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: The requirement of extracellular signal-regulated kinase, p38, c-Jun N-terminal kinase and NF-αB pathways for the expression of proinflammatory cytokines and nitric oxide, " Journal of Biological Chemistry, vol. 280, no. 9, pp. 8617-8627, 2005.
101. G. Krishnegowda, A. M. Hajjar, J. Zhu et al. , "Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity, " Journal of Biological Chemistry, vol. 280, no. 9, pp. 8606-8616, 2005.
102. J. Zhu, X. Wu, S. Goel et al. , "MAPK-activated protein kinase 2 differentially regulates plasmodium falciparum glycosylphosphatidylinositol-inducedproduction of tumor necrosis Factor-α and interleukin-12 in macrophages, " The Journal of Biological Chemistry, vol. 284, no. 23, pp. 15756-15761, 2009.
103. J. Zhu, R. Weinberg, X. Wu, N. M. Gowda, T. Muta, and D. C. Gowda, "Ikappab-zeta plays an important role in the ERKdependent dysregulation of malaria parasite GPI-induced IL-12 expression, " IUBMB Life, vol. 64, no. 2, pp. 187-193, 2012.
104. C. Coban, K. J. Ishii, T. Kawai et al. , "Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin, " The Journal of Experimental Medicine, vol. 201, no. 1, pp. 19-25, 2005.
105. P. Parroche, F. N. Lauw, N. Goutagny et al. , "Malariahemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 6, pp. 1919-1924, 2007.
106. V. Barrera, O. A. Skorokhod, D. Baci, G. Gremo, P. Arese, and E. Schwarzer, "Host fibrinogen stably bound to hemozoin rapidly activates monocytes via TLR-4 and CD11b/CD18-integrin: A new paradigm of hemozoin action, " Blood, vol. 117, no. 21, pp. 5674-5682, 2011.
107. B. B. Andrade, T. Araujo-Santos, N. F. Luz et al. , "Heme impairs prostaglandin E2 and TGF-β production by human mononuclear cells viaCu/Zn superoxide dismutase: insight into the pathogenesis of severemalaria, "The Journal of Immunology, vol. 185, no. 2, pp. 1196-1204, 2010.
108. R. T. Figueiredo, P. L. Fernandez, D. S. Mourao-Sa et al. , "Characterization of heme as activator of toll-like receptor 4, " The Journal of Biological Chemistry, vol. 282, no. 28, pp. 20221-20229, 2007.
109. K. N. Couper, T. Barnes, J. C. R. Hafalla et al. , "Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation, " PLoS Pathogens, vol. 6, no. 1, Article ID e1000744, 2010.
110. A. Baccarella, M. F. Fontana, E. Chen, and C. C. Kim, "Toll-like receptor 7 mediates early innate immune responses to malaria, " Infection and Immunity, vol. 81, no. 12, pp. 4431-4442, 2013.
111. T. K. Bhatt, A. Sharma, S. Khan et al. , "Malaria parasite tyrosyl-tRNA synthetase secretion triggers pro-inflammatory responses, " Nature Communications, vol. 2, no. 1, article 530, 2011.
112. K. Kumar, A. Singal, M. M. A. Rizvi, and V. S. Chauhan, "High mobility group box (HMGB) proteins of Plasmodium falciparum: DNA binding proteins with pro-inflammatory activity, " Parasitology International, vol. 57, no. 2, pp. 150-157, 2008.
113. L. Hamann, G. Bedu-Addo, T. A. Eggelte, R. R. Schumann, and F. P. Mockenhaupt, "The toll-like receptor 1 variant S248N influences placental malaria, " Infection, Genetics and Evolution, vol. 10, no. 6, pp. 785-789, 2010.
114. F. M. S. Leoratti, L. Farias, F. P. Alves et al. , "Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria, "The Journal of Infectious Diseases, vol. 198, no. 5, pp. 772-780, 2008.
115. J. A. Greene, N. Sam-Agudu, C. C. John, R. O. Opoka, P. A. Zimmerman, and J. W. Kazura, "Toll-like receptor polymorphisms and cerebral malaria: TLR2 δ22 polymorphism is associated with protection from cerebral malaria in a case control study, " Malaria Journal, vol. 11, no. 47, pp. 1475-2875, 2012.
116. S. Zakeri, S. Pirahmadi, A. A. Mehrizi, and N. D. Djadid, "Genetic variation of TLR-4, TLR-9 and TIRAP genes in Iranian malaria patients, " Malaria Journal, vol. 10, article 77, 2011.
117. S. Esposito, C. G. Molteni, A. Zampiero et al. , "Role of polymorphisms of toll-like receptor (TLR) 4, TLR9, toll-interleukin 1 receptor domain containing adaptor protein (TIRAP) and FCGR2A genes in malaria susceptibility and severity in Burundian children, " Malaria Journal, vol. 11, article 196, 2012.
118. F. P. Mockenhaupt, L. Hamann, C. Von Gaertner et al. , "Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy, " Journal of Infectious Diseases, vol. 194, no. 2, pp. 184-188, 2006.
119. F. P. Mockenhaupt, J. P. Cramer, L. Hamann et al. , "Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 1, pp. 177-182, 2006.
120. A. H. Omar, M. Yasunami, A. Yamazaki et al. , "Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study, " Malaria Journal, vol. 11, article 168, pp. 1475-2875, 2012.
121. N. A. Sam-Agudu, J. A. Greene, R. O. Opoka et al. , "TLR9 polymorphisms are associated with altered IFN-γlevels in children with cerebral malaria, " The American Journal of Tropical Medicine and Hygiene, vol. 82, no. 4, pp. 548-555, 2010.
122. C. C. Khor, S. J. Chapman, F. O. Vannberg et al. , "A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis, " Nature Genetics, vol. 39, no. 4, pp. 523-528, 2007.
123. V. D. Mangano, G. Luoni, K. A. Rockett et al., Interferon regulatory factor-1 polymorphisms are associated with the control of Plasmodium falciparum infection, Genes & Immunity, vol. 9, no. 2, pp. 122129, 2008.
124. V. D.Mangano, T. G. Clark, S. Auburnet al., Lackof association of interferon regulatory factor 1 with severe malaria in affected child-parental trio studies across three African populations, PLoS ONE, vol. 4, no. 1,Article ID e4206, 2009.
125. R. S. Tan, C. Feng, Y. Asano, and A. U. Kara, "Altered immune response of interferon regulatory factor 1-deficient mice against Plasmodium berghei blood-stage malaria infection, " Infection and Immunity, vol. 67, no. 5, pp. 2277-2283, 1999.
126. J. L. Miller, B. K. Sack, M. Baldwin, A. M. Vaughan, and S. H. Kappe, "Interferon-mediated innate immune responses against malaria parasite liver stages, " Cell Reports, vol. 7, no. 2, pp. 436-447, 2014.
127. N. J. Gay and M. Gangloff, "Structure and function of toll receptors and their ligands, " Annual Review of Biochemistry, vol. 76, pp. 141-145, 2007.
128. O. Takeuchi and S. Akira, "Pattern recognition receptors and inflammation, " Cell, vol. 140, no. 6, pp. 805-820, 2010.
129. E. M. Pietras, S. K. Saha, and G. Cheng, "The interferon response to bacterial and viral infections, " Journal of Endotoxin Research, vol. 12, no. 4, pp. 246-250, 2006.
130. A. K. Perry, G. Chen, D. Zheng, H. Tang, and G. Cheng, "The host type I interferon response to viral and bacterial infections, " Cell Research, vol. 15, no. 6, pp. 407-422, 2005.
131. J. Currier, H. Beck, B. Currie, and M. F. Good, "Antigens released at schizont burst stimulate Plasmodium falciparumspecific CD4+ T cells from non-exposed donors: Potential for cross-reactive memory T cells to cause disease, " International Immunology, vol. 7, no. 5, pp. 821-833, 1995.
132. K. P. ODea and G. Pasvol, "Optimal tumor necrosis factor induction by Plasmodiumfalciparumrequires the highly localized release of parasite products, " Infection and Immunity, vol. 71, no. 6, pp. 3155-3164, 2003.
133. D. Kwiatkowski, J. G. Cannon, K. R. Manogue, A. Cerami, C. A. Dinarello, and B. M. Greenwood, "Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture, " Clinical and Experimental Immunology, vol. 77, no. 3, pp. 361-366, 1989.
134. S. F. Kitchen, "Symptomology: general considerations, " in Malariology: A Comprehensive Survey of all Aspects of this Group of Diseases from a Global Standpoint, Saunders, Philadelphia, Pa, USA, 1949.
135. P. Gerold, L. Schofield, M. J. Blackman, A. A. Holder, and R. T. Schwarz, "Structural analysis of the glycosylphosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum, "Molecular and Biochemical Parasitology, vol. 75, no. 2, pp. 131-143, 1996.
136. V. K. Goel, X. Li, H. Chen, S. C. Liu, A. H. Chishti, and S. S. Oh, "Band 3 is a host receptor bindingmerozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 9, pp. 5164-5169, 2003.
137. D. T. Riglar, D. Richard, D. W. Wilson et al. , "Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte, " Cell Host and Microbe, vol. 9, no. 1, pp. 9-20, 2011.
138. J. A. Dvorak, L. H. Miller, W. C. Whitehouse, and T. Shiroishi, "Invasion of erythrocytes by malaria merozoites, " Science, vol. 187, no. 4178, pp. 748-750, 1975.
139. M. J. Boyle, C. Langer, J. A. Chan et al. , "Sequential processing of merozoite surface proteins during and after erythrocyte invasion by Plasmodium falciparum, " Infection and Immunity, vol. 82, no. 3, pp. 924-936, 2014.
140. M. Aikawa, L. H. Miller, J. Johnson, and J. Rabbege, "Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite, " Journal of Cell Biology, vol. 77, no. 1, pp. 72-82, 1978.
141. M. Chugh, V. Sundararaman, S. Kumar et al. , "Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 14, pp. 5392-5397, 2013.
142. S. Kapishnikov, A. Weiner, E. Shimoni et al. , "Oriented nucleation of hemozoin at the digestive vacuole membrane in Plasmodium falciparum, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 28, pp. 11188-11193, 2012.
143. S. Kapishnikov, A. Weiner, E. Shimoni, G. Schneider, M. Elbaum, and L. Leiserowitz, "Digestive vacuole membrane in Plasmodium falciparum infected erythrocytes: relevance to templated nucleation of hemozoin, " Langmuir, vol. 29, no. 47, pp. 14595-14602, 2013.
144. M. Abkarian, G. Massiera, L. Berry, M. Roques, and C. Braun-Breton, "A novel mechanism for egress of malarial parasites from red blood cells, " Blood, vol. 117, no. 15, pp. 4118-4124, 2011.
145. C. Coban, Y. Igari, M. Yagi et al. , "Immunogenicity of wholeparasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9, " Cell Host and Microbe, vol. 7, no. 1, pp. 50-61, 2010.
146. C. Hashimoto, K. L. Hudson, and K. V. Anderson, "The Toll gene of drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein, " Cell, vol. 52, no. 2, pp. 269-279, 1988.
147. R. Medzhitov, P. Preston-Hurlburt, and C. A. Janeway Jr. , "A human homologue of the Drosophila toll protein signals activation of adaptive immunity, " Nature, vol. 388, no. 6640, pp. 394-397, 1997.
148. S. Pandey and D. K. Agrawal, "Immunobiology of Toll-like receptors: emerging trends, " Immunology and Cell Biology, vol. 84, no. 4, pp. 333-341, 2006.
149. T. Chuang and R. J. Ulevitch, "Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells, " Biochimica et Biophysica Acta: Gene Structure and Expression, vol. 1518, no. 1-2, pp. 157-161, 2001.
150. F. Yarovinsky, "Innate immunity to Toxoplasma gondii infection, " Nature Reviews Immunology, vol. 14, no. 2, pp. 109-121, 2014.
151. T. Kawai and S. Akira, "Pathogen recognition with Toll-like receptors, " Current Opinion in Immunology, vol. 17, no. 4, pp. 338-344, 2005.
152. T. Kawai and S. Akira, "TLR signaling, " Cell Death and Differentiation, vol. 13, no. 5, pp. 816-825, 2006.
153. L. Schofield and F. Hackett, "Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites, " Journal of Experimental Medicine, vol. 177, no. 1, pp. 145-153, 1993.
154. S. D. Tachado, P. Gerold, M. J. McConville et al. , "Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway, " Journal of Immunology, vol. 156, no. 5, pp. 1897-1907, 1996.
155. X. Wu, N. M. Gowda, S. Kumar, and D. C. Gowda, "Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses, " The Journal of Immunology, vol. 184, no. 8, pp. 4338-4348, 2010.
156. S. Pichyangkul, K. Yongvanitchit, U. Kum-Arb et al. , "Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a toll-like receptor 9-dependent pathway, " Journal of Immunology, vol. 172, no. 8, pp. 4926-4933, 2004.
157. E. Hempelmann and T. J. Egan, "Pigment biocrystallization in Plasmodium falciparum, " Trends in Parasitology, vol. 18, no. 1, article 11, 2002.
158. B. S. Franklin, P. Parroche, M. A. Ataide et al. , "Malaria primes the innate immune response due to interferon-γ induced enhancement of toll-like receptor expression and function, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5789-5794, 2009.
159. V. Jeney, J. Balla, A. Yachie et al. , "Pro-oxidant and cytotoxic effects of circulating heme, " Blood, vol. 100, no. 3, pp. 879-887, 2002.
160. J. Balla, G. Balla, V. Jeney, G. Kakuk, H. S. Jacob, and G. M. Vercellotti, "Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants, " Blood, vol. 95, no. 11, pp. 3442-3450, 2000.
161. J. Balla, H. S. Jacob, G. Balla, K. Nath, J. W. Eaton, and G. M. Vercellotti, "Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage, " Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 20, pp. 9285-9289, 1993.
162. E. Seixas, R. Gozzelino, A. Chora et al. , "Heme oxygenase-1 affords protection against noncerebral forms of severemalaria, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 37, pp. 15837-15842, 2009.
163. M. A. Arruda, A. G. Rossi, M. S. De Freitas, C. Barja-Fidalgo, and A. V. Graca-Souza, "Heme inhibits human neutrophil apoptosis: involvement of phosphoinositide 3-kinase, MAPK, and NF-αB, " Journal of Immunology, vol. 173, no. 3, pp. 2023-2030, 2004.
164. A. V. Graca-Souza, M. A. B. Arruda, M. S. de Freitas, C. Barja-Fidalgo, and P. L. Oliveira, "Neutrophil activation by heme: implications for inflammatory processes, " Blood, vol. 99, no. 11, pp. 4160-4165, 2002.
165. B. N. Porto, L. S. Alves, P. L. Fernandez et al. , "Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors, " Journal of Biological Chemistry, vol. 282, no. 33, pp. 24430-24436, 2007.
166. S. Nomura, N. N. Tandon, T. Nakamura, J. Cone, S. Fukuhara, and J. Kambayashi, "High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells, " Atherosclerosis, vol. 158, no. 2, pp. 277-287, 2001.
167. S. F. Mause, P. von Hundelshausen, A. Zernecke, R. R. Koenen, and C. Weber, "Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 7, pp. 1512-1518, 2005.
168. N. Amabile, A. P. Guerin, A. Leroyer et al. , "Circulating endothelial microparticles are associatedwith vascular dysfunction in patients with end-stage renal failure, " Journal of the American Society of Nephrology, vol. 16, no. 11, pp. 3381-3388, 2005.
169. C. M. Boulanger, A. Scoazec, T. Ebrahimian et al. , "Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction, " Circulation, vol. 104, no. 22, pp. 2649-2652, 2001.
170. B. Fritzsching, B. Schwer, J. Kartenbeck, A. Pedal, V. Horejsi, and M. Ott, "Release and intercellular transfer of cell surface CD81 via microparticles, " Journal of Immunology, vol. 169, no. 10, pp. 5531-5537, 2002.
171. M. Baj-Krzyworzeka, R. Szatanek, K. Weglarczyk et al. , "Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes, " Cancer Immunology, Immunotherapy, vol. 55, no. 7, pp. 808-818, 2006.
172. V. Combes, N. Coltel, M. Alibert et al. , "ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology, " The American Journal of Pathology, vol. 166, no. 1, pp. 295-302, 2005.
173. Z. M. Khan, C. Ng, and J. P. Vanderberg, "Early hepatic stages of Plasmodiumberghei: release of circumsporozoite protein and host cellular inflammatory response, " Infection and Immunity, vol. 60, no. 1, pp. 264-270, 1992.
174. S. Epiphanio, S. A. Mikolajczak, L. A. Goncalves et al. , "Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver Infection, " CellHost andMicrobe, vol. 3, no. 5, pp. 331-338, 2008.
175. N. A. De Weerd and T. Nguyen, "The interferons and their receptors-distribution and regulation, " Immunology and Cell Biology, vol. 90, no. 5, pp. 483-491, 2012.
176. M. J. de Veer, M. Holko, M. Frevel et al. , "Functional classification of interferon-stimulated genes identified using microarrays, " Journal of Leukocyte Biology, vol. 69, no. 6, pp. 912-920, 2001.
177. G. Trinchieri, "Type I interferon: friend or foe?" Journal of Experimental Medicine, vol. 207, no. 10, pp. 2053-2063, 2010.
178. H. Hisamatsu, N. Shimbara, Y. Saitoet al. , "Newly identifiedpair of proteasomal subunits regulated reciprocally by interferon γ, " Journal of Experimental Medicine, vol. 183, no. 4, pp. 1807-1816, 1996.
179. B. Boes, H. Hengel, T. Ruppert, G. Multhaup, U. H. Koszinowski, and P. Kloetzel, "Interferon γ stimulationmodulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes, " The Journal of Experimental Medicine, vol. 179, no. 3, pp. 901-909, 1994.
180. L. A. Cramer, S. L. Nelson, and M. J. Klemsz, "Synergistic induction of the Tap-1 gene by IFN-γ and lipopolysaccharide in macrophages is regulated by STAT1, " The Journal of Immunology, vol. 165, no. 6, pp. 3190-3197, 2000.
181. D. Wallach, M. Fellous, and M. Revel, "Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells, " Nature, vol. 299, no. 5886, pp. 833-836, 1982.
182. D. V. Erbe, J. E. Collins, L. Shen, R. F. Graziano, and M. W. Fanger, "The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells, " Molecular Immunology, vol. 27, no. 1, pp. 57-67, 1990.
183. R. C. Strunk, F. S. Cole, D. H. Perlmutter, and H. R. Colten, "γ-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes, " Journal of Biological Chemistry, vol. 260, no. 28, pp. 15280-15285, 1985.
184. D. A. Drevets, P. J. M. Leenen, and P. A. Campbell, "Complement receptor type 3 mediates phagocytosis and killing of Listeria monocytogenes by a TNF-α-and IFN-γ-stimulated macrophage precursor hybrid, " Cellular Immunology, vol. 169, no. 1, pp. 1-6, 1996.
185. A. Yoshida, Y. Koide, M. Uchijima, and T. O. Yoshida, "IFN-γ induces IL-12 mRNA expression by a murine macrophage cell line, J774, " Biochemical and Biophysical Research Communications, vol. 198, no. 3, pp. 857-861, 1994.
186. M. P. Gil, E. Bohn, A. K. OGuin et al. , "Biologic consequences of Stat1-independent IFN signaling, " Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 12, pp. 6680-6685, 2001.
187. D. D. Taub, A. R. Lloyd, K. Conlon et al. , "Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells, "The Journal of ExperimentalMedicine, vol. 177, no. 6, pp. 1809-1814, 1993.
188. A. Ferreira, L. Schofield, V. Enea et al. , "Inhibition of development of exoerythrocytic froms of malaria parasites by γ-interferon, " Science, vol. 232, no. 4752, pp. 881-884, 1986.
189. L. Schofield, A. Ferreira, R. Altszuler, V. Nussenzweig, and R. S. Nussenzweig, "Interferon-γ inhibits the intrahepatocytic development of malaria parasites in vitro, " The Journal of Immunology, vol. 139, no. 6, pp. 2020-2025, 1987.
190. S. Mellouk, S. J. Green, C. A. Nacy, and S. L. Hoffman, "IFN-γ inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism, " Journal of Immunology, vol. 146, no. 11, pp. 3971-3976, 1991.
191. A. K. Nussler, L. Renia, V. Pasquetto, F. Miltgen, H. Matile, and D. Mazier, "In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants, " European Journal of Immunology, vol. 23, no. 4, pp. 882-887, 1993.
192. A. J. F. Luty, B. Lell, R. Schmidt-Ott et al. , "Interferon-γ responses are associated with resistance to reinfection with Plasmodium falciparum in young African children, " Journal of Infectious Diseases, vol. 179, no. 4, pp. 980-988, 1999.
193. B. Perlaza, J. Sauzet, K. Brahimi, L. Benmohamed, and P. Druilhe, "Interferon-γ, a valuable surrogatemarker of Plasmodium falciparum pre-erythrocytic stages protective immunity, " Malaria Journal, vol. 10, article 27, 2011.
194. L. Schofield, J. Villaquiran, A. Ferreira, H. Schellekens, R. Nussenzweig, and V. Nussenzweig, "Gamma Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites, " Nature, vol. 330, no. 6149, pp. 664-666, 1987.
195. M. M. Stevenson, M. F. Tam, M. Belosevic, P. H. van derMeide, and J. E. Podoba, "Role of endogenous gamma interferon in host response to infection with blood-stage Plasmodium chabaudi AS, " Infection and Immunity, vol. 58, no. 10, pp. 3225-3232, 1990.
196. T. Yoneto, T. Yoshimoto, C. Wang et al. , "Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical, " Infection and Immunity, vol. 67, no. 5, pp. 2349-2356, 1999.
197. M. C. DOmbrain, L. J. Robinson, D. I. Stanisic et al. , "Association of early interferon-γ production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children, " Clinical Infectious Diseases, vol. 47, no. 11, pp. 1380-1387, 2008.
198. S. Inoue, M. Niikura, S. Mineo, and F. Kobayashi, "Roles of IFNgamma and gammadelta T Cells in protective immunity against blood-stage malaria, " Frontiers in Immunology, vol. 4, article 258, 2013.
199. A. J. F. Luty, D. J. Perkins, B. Lell et al. , "Low interleukin-12 activity in severe Plasmodium falciparum malaria, " Infection and Immunity, vol. 68, no. 7, pp. 3909-3915, 2000.
200. C. Aucan, A. J. Walley, B. J. W. Hennig et al. , "Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebralmalaria inTheGambia, "Genes&Immunity, vol. 4, no. 4, pp. 275-282, 2003.
201. D. P. Simmons, P. A. Wearsch, D. H. Canaday et al. , "Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing, " Journal of Immunology, vol. 188, no. 7, pp. 3116-3126, 2012.
202. J. M. Curtsinger, J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher, "Cutting edge: type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation, " Journal of Immunology, vol. 174, no. 8, pp. 4465-4469, 2005.
203. P. Agarwal, A. Raghavan, S. L. Nandiwada et al. , "Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory, " Journal of Immunology, vol. 183, no. 3, pp. 1695-1704, 2009.
204. C. A. Hunter, K. E. Gabriel, T. Radzanowski, L. E. Neyer, and J. S. Remington, "Type I interferons enhance production of IFN-γ by NK cells, " Immunology Letters, vol. 59, no. 1, pp. 1-5, 1997.
205. D. J. Gough, N. L. Messina, L. Hii et al. , "Functional crosstalk between type I and II interferon through the regulated expression of STAT1, " PLoS Biology, vol. 8, no. 4, Article ID e1000361, 2010.
206. R. I. Jahiel, J. Vilcek, and R. S. Nussenzweig, "Exogenous interferon protects mice against Plasmodium berghei malaria, " Nature, vol. 227, no. 5265, pp. 1350-1351, 1970.
207. J. Van Damme, M. R. Schaafsma, W. E. Fibbe, J. H. F. Falkenburg, G. Opdenakker, and A. Billiau, "Simultaneous production of interleukin 6, interferon-β and colony-stimulating activity by fibroblasts after viral and bacterial infection, " European Journal of Immunology, vol. 19, no. 1, pp. 163-168, 1989.
208. A. Nussler, J.-A. Drapier, L. Renia et al. , "L-Arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation, " European Journal of Immunology, vol. 21, no. 1, pp. 227-230, 1991.
209. I. Landau and P. Gautret, "Animal models: rodents, " in Malaria: Parasite Biology, Pathogenesis, and Protection, I. W. Sherman, Ed. , pp. 401-417, ASM Press, Washington, DC, USA, 1998.
210. A. M. Vigario, E. Belnoue, A. C. Gruner et al. , "Recombinant human IFN-α inhibits cerebral malaria and reduces parasite burden in mice, " Journal of Immunology, vol. 178, no. 10, pp. 6416-6425, 2007.
211. M. Krupka, K. Seydel, C. M. Feintuch et al. , "Mild Plasmodium falciparum malaria following an episode of severe malaria is associated with induction of the interferon pathway in Malawian children, " Infection and Immunity, vol. 80, no. 3, pp. 1150-1155, 2012.
212. T. Taniguchi, K. Ogasawara, A. Takaoka, and N. Tanaka, "IRF family of transcription factors as regulators of host defense, " Annual Review of Immunology, vol. 19, pp. 623-655, 2001.
213. K. Ozato, P. Tailor, and T. Kubota, "The interferon regulatory factor family in host defense: mechanism of action, " Journal of Biological Chemistry, vol. 282, no. 28, pp. 20065-20069, 2007.
214. A. Kroger, M. Koster, K. Schroeder, H. Hauser, and P. P. Mueller, "Activities of IRF-1, " Journal of Interferon and Cytokine Research, vol. 22, no. 1, pp. 5-14, 2002.
215. K. Honda, A. Takaoka, and T. Taniguchi, "Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors, " Immunity, vol. 25, no. 3, pp. 349-360, 2006.
216. P. Rihet, Y. Traore, L. Abel, C. Aucan, T. Traore-Leroux, and F. Fumoux, "Malaria in humans: plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33, " American Journal of Human Genetics, vol. 63, no. 2, pp. 498-505, 1998.
217. K. Honda, H. Yanai, A. Takaoka, and T. Taniguchi, "Regulation of the type I IFN induction: a current view, " International Immunology, vol. 17, no. 11, pp. 1367-1378, 2005.
218. Y. Liu, L. Zeng, A. T. Tian et al. , "Endoplasmic reticulum stress regulates the innate immunity critical transcription factor IRF3, " Journal of Immunology, vol. 189, no. 9, pp. 4630-4639, 2012.
219. M. Yoneyama, W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida, and T. Fujita, "Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300, " EMBO Journal, vol. 17, no. 4, pp. 1087-1095, 1998.
220. M. G. Wathelet, C. H. Lin, B. S. Parekh, L. V. Ronco, P. M. Howley, and T. Maniatis, "Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo, "Molecular Cell, vol. 1, no. 4, pp. 507-518, 1998.
221. J. Yie, K. Senger, and D. Thanos, "Mechanism by which the IFN-β enhanceosome activates transcription, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 23, pp. 13108-13113, 1999.
222. M. Sato, N. Hata, M. Asagiri, T. Nakaya, T. Taniguchi, and N. Tanaka, "Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7, " FEBS Letters, vol. 441, no. 1, pp. 106-110, 1998.
223. D. L. Noah, M. A. Blum, and B. Sherry, "Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte cultures, " Journal of Virology, vol. 73, no. 12, pp. 10208-10213, 1999.
224. C. F. Basler, A. Mikulasova, L. Martinez-Sobrido et al. , "The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3, " Journal of Virology, vol. 77, no. 14, pp. 7945-7956, 2003.
225. J. Ye and T. Maniatis, "Negative regulation of interferon-β gene expression during acute and persistent virus infections, " PLoS ONE, vol. 6, no. 6, Article ID e20681, 2011.
226. M. Sagong and C. Lee, "Porcine reproductive and respiratory syndrome virus nucleocapsid protein modulates interferon-β production by inhibiting IRF3 activation in immortalized porcine alveolarmacrophages, " Archives of Virology, vol. 156, no. 12, pp. 2187-2195, 2011.
227. T. Tamura and K. Ozato, "ICSBP/IRF-8: its regulatory roles in the development of myeloid cells, " Journal of Interferon and Cytokine Research, vol. 22, no. 1, pp. 145-152, 2002.
228. M. Horiuchi, A. Itoh, D. Pleasure, K. Ozato, and T. Itoh, "Cooperative contributions of interferon regulatory factor 1 (IRF1) and IRF8 to interferon-γ-mediated cytotoxic effects on oligodendroglial progenitor cells, " Journal of Neuroinflammation, vol. 8, article 8, pp. 1742-2094, 2011.
229. P. H. Driggers, D. L. Ennist, S. L. Gleasonet al. , "An interferonγ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 10, pp. 3743-3747, 1990.
230. J. Nitcheu, O. Bonduelle, C. Combadiere et al. , "Perforindependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebralmalaria pathogenesis, " Journal of Immunology, vol. 170, no. 4, pp. 2221-2228, 2003.
231. G. L. Suidan, J. R. Mcdole, Y. Chen, I. Pirko, and A. J. Johnson, "Induction of blood brain barrier tight junction protein alterations by CD8 T cells, " PLoS ONE, vol. 3, no. 8, Article IDe3037, 2008.
232. M. Fauconnier, J. Palomo, M. L. Bourigault et al. , "IL-12Rβ2 is essential for the development of experimental cerebralmalaria, " The Journal of Immunology, vol. 188, no. 4, pp. 1905-1914, 2012.
233. B. J. Barnes, P. A. Moore, and P. M. Pitha, "Virus-specific activation of a novel Interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes, " The Journal of Biological Chemistry, vol. 276, no. 26, pp. 23382-23390, 2001.
234. B. J. Barnes, M. J. Kellum, A. E. Field, and P. M. Pitha, "Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes, " Molecular and Cellular Biology, vol. 22, no. 16, pp. 5721-5740, 2002.
235. X. Y. Fu, D. S. Kessler, S. A. Veals, D. E. Levy, and J. E. Darnell Jr. , "ISGF3, the transcriptional activator induced by interferon α, consists ofmultiple interacting polypeptide chains, " Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 21, pp. 8555-8559, 1990.
236. S. A. Qureshi, M. Salditt-Georgieff, and J. E. Darnell Jr. , "Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3, " Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 9, pp. 3829-3833, 1995.
237. C. J. Sutherland, A. Alloueche, J. Curtis et al. , "Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes, " The American Journal of TropicalMedicine and Hygiene, vol. 67, no. 6, pp. 578-585, 2002.
238. K. Na-Bangchang, P. Muhamad, R. Ruaengweerayut, W. Chaijaroenkul, and J. Karbwang, "Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity, " Malaria Journal, vol. 12, no. 1, article 263, 2013.
239. J. Hadden, "Recent thoughts on the immunotherapy of infectious diseases including HIV infection, " in Microbial Infections, H. Friedman, T. Klein, and H. Yamaguchi, Eds. , pp. 13-22, Springer, 1992.
240. M. Jeffrey and M. Jacobson, "Immunotherapy for infectious diseases, " in Infectious Disease, V. S. Georgiev, Ed. , p. 331, Humana Press, New York, NY, USA, 2002.
241. V. Kak, V. Sundareshan, J. Modi, and N. M. Khardori, "Immunotherapies in infectious diseases, " Medical Clinics of North America, vol. 96, no. 3, pp. 455-474, 2012.
242. M. Talpaz, H. M. Kantarjian, K. McCredie, J. M. Trujillo, M. J. Keating, and J. U. Gutterman, "Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha(A) in chronic myelogenous leukemia, " The New England Journal ofMedicine, vol. 314, no. 17, pp. 1065-1069, 1986.
243. D. Goldstein and J. Laszlo, "The role of interferon in cancer therapy: a current perspective, " Ca: A Cancer Journal for Clinicians, vol. 38, no. 5, pp. 258-277, 1988.
244. J. M. Kirkwood, M. S. Ernstoff, C. A. Davis, M. Reiss, R. Ferraresi, and S. A. Rudnick, "Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers, " Annals of Internal Medicine, vol. 103, no. 1, pp. 32-36, 1985.
245. L. Repetto, P. G. Giannessi, E. Campora et al. , "Tamoxifen and interferon-beta for the treatment of metastatic breast cancer, " Breast Cancer Research and Treatment, vol. 39, no. 2, pp. 235-238, 1996.
246. G. H. Windbichler, H. Hausmaninger, W. Stummvoll et al. , "Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial, " British Journal of Cancer, vol. 82, no. 6, pp. 1138-1144, 2000.
247. M. L. Shiffman, "Pegylated interferons: what role will they play in the treatment of chronic hepatitis C?" Current Gastroenterology Reports, vol. 3, no. 1, pp. 30-37, 2001.
248. G. Chander, M. S. Sulkowski, M. W. Jenckes et al. , "Treatment of chronic hepatitis C: a systematic review, " Hepatology, vol. 36, no. 5, supplement 1, pp. S135-S144, 2002.
249. J. Yang, Y. G. Pu, Z. M. Zeng et al. , "Interferon for the treatment of genital warts: a systematic review, " BMC Infectious Diseases, vol. 9, no. 156, pp. 1471-2334, 2009.
250. A. H. Achtman, S. Pilat, C. W. Law et al. , "Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria, " Science TranslationalMedicine, vol. 4, no. 135, Article ID135ra64, 2012.